Ryo Takata
Overview
Explore the profile of Ryo Takata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
2220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawamura T, Ikarashi D, Machida A, Tamura D, Matsuura T, Maekawa S, et al.
Cureus
. 2024 Jul;
16(6):e61479.
PMID: 38952589
Introduction Decreased renal function after radical nephroureterectomy is one of the most important complications because it contributes to the decision to initiate adjuvant chemotherapy. This study aimed to investigate clinical...
2.
Takahashi K, Kato R, Ikarashi D, Matsuura T, Maekawa S, Kanehira M, et al.
IJU Case Rep
. 2024 Mar;
7(2):131-135.
PMID: 38440705
Introduction: Patients with translocation renal cell carcinoma (tRCC) have a poor prognosis without standardized treatment. Case Presentation: The first case was of a 72-year-old woman who underwent robot-assisted partial nephrectomy...
3.
Maekawa S, Takata R, Obara W
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339274
The progression of prostate cancer (PCa) relies on the activation of the androgen receptor (AR) by androgens. Despite efforts to block this pathway through androgen deprivation therapy, resistance can occur...
4.
Ikarashi D, Kitano S, Tsuyukubo T, Yamashita M, Matsuura T, Maekawa S, et al.
Sci Rep
. 2024 Jan;
14(1):1442.
PMID: 38228697
The prognosis for patients who achieve a pathologic complete response in bladder cancer is excellent, but the association between their prognosis and the tumor microenvironment is unclear. We investigated the...
5.
Abe M, Takata R, Ikarashi D, Sekiguchi K, Tamura D, Maekawa S, et al.
Prostate Int
. 2024 Jan;
11(4):212-217.
PMID: 38196555
Background: Prostate cancer in the anterior region may be missed on a transrectal systematic biopsy (SBx). Therefore, this study aimed to evaluate the performance of magnetic resonance imaging-transrectal ultrasound (MRI-TRUS)...
6.
Maekawa S, Takata R, Sekiguchi K, Kagabu M, Toyoshima M, Tamada S, et al.
Jpn J Clin Oncol
. 2023 Dec;
54(4):489-497.
PMID: 38157885
Objective: The companion diagnosis for olaparib, a poly (ADP-ribose) polymerase inhibitor for prostate cancer, aims to detect BRCA1/2 gene variants. In clinical practice, the frequency of germline BRCA1/2 variants in...
7.
Sekiguchi K, Abe T, Shiomi E, Ikarashi D, Matsuura T, Maekawa S, et al.
Ther Apher Dial
. 2023 Dec;
28(3):364-370.
PMID: 38087844
Introduction: We aimed to determine whether unfractionated heparin (UH) and low molecular weight heparin (LH) contribute to aberrant carnitine metabolism in patients receiving hemodialysis. Methods: The rate of increase in...
8.
Tamura D, Abe M, Hiraki H, Sasaki N, Yashima-Abo A, Ikarashi D, et al.
Cancer Sci
. 2023 Dec;
115(2):529-539.
PMID: 38083992
Biomarkers that could detect the postoperative recurrence of upper tract urothelial carcinoma (UTUC) have not been established. In this prospective study, we aim to evaluate the utility of individualized circulating...
9.
Tamada S, Ikarashi D, Yanagawa N, Toyoshima M, Takahashi K, Matsuura T, et al.
Front Oncol
. 2023 Nov;
13:1274494.
PMID: 38023224
We report the case of a 68-year-old man who developed a sigmoidorectal fistula after marked response to enfortumab vedotin for advanced bladder cancer. The patient had undergone radical cystectomy with...
10.
Toyoshima M, Ikarashi D, Tsuboi H, Moriwaka M, Tamada S, Matsuura T, et al.
Hinyokika Kiyo
. 2023 Sep;
69(8):227-232.
PMID: 37667600
A 73-year-old man with renal cell carcinoma underwent a left-sided open radical nephrectomy at our center. The pathological diagnosis was Fuhrman Grade 2, stage pT3a, clear cell renal cell carcinoma....